Form 4: SMG CFO Acquires Shares, Options Under 10b5-1 Plan

Scotts Miracle-Gro's EVP, CFO & CAO, Mark J. Scheiwer, acquired common shares and stock options under a pre-arranged 10b5-1 trading plan.

Summary

• Mark J. Scheiwer, EVP, CFO & CAO of The Scotts Miracle-Gro Company (SMG), engaged in transactions on January 30, 2026.
• Acquired 2.888 common shares at a price of $51.93 per share.
• Acquired 29,649 stock options (right to buy) with an exercise price of $64.22 per share.
• The stock options become exercisable on January 30, 2029, and expire on January 30, 2036.
• The transactions were made pursuant to a Rule 10b5-1(c) trading plan.
• Following these transactions, Scheiwer directly owns 15,288.741 common shares and 29,649 stock options.
• Additionally, 493.482 common shares are indirectly owned through a 401(K) Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine insider transaction, slightly positive due to executive share acquisition and option grants aligning interests, but not indicative of significant new company performance data.

Positives

• An executive acquiring shares, even a small amount, can signal confidence in the company's future performance.
• The grant of a significant number of stock options (29,649) aligns the executive's interests with long-term shareholder value.
• Use of a 10b5-1 plan indicates pre-planned transactions, reducing concerns about insider trading based on non-public information.

Negatives

• The number of common shares acquired (2.888) is very small, suggesting it might be part of a routine compensation or dividend reinvestment rather than a significant personal investment.

Future Outlook

This filing is a transaction report and does not contain forward-looking statements or guidance regarding the company's future performance, beyond the specified exercisable and expiration dates for the stock options.

Industry Context

StockSavvy.ai notes that insider transactions, particularly option grants, are common executive compensation tools across industries, aiming to align management incentives with long-term shareholder value. The use of a 10b5-1 plan is a standard practice for executives to manage their stock transactions in compliance with insider trading regulations.

Comparison to Industry Standards

• The grant of stock options is a standard component of executive compensation packages across various industries, including consumer goods and agriculture, similar to practices at companies like Bayer AG (which owns Monsanto) or Corteva Agriscience.
• The volume of options granted (29,649) is substantial for an EVP/CFO, comparable to grants seen in similar-sized companies, reflecting a significant incentive component.
• The exercise price of $64.22, being above the acquisition price of the common shares ($51.93), suggests the options are 'at-the-money' or 'out-of-the-money' at the time of grant, requiring stock price appreciation for value realization, a common structure to incentivize growth.

Corporate Governance

Stakeholder Impact

• Shareholders: Executive's interests are further aligned with long-term share price appreciation due to option grants.

Key Dates

Recommendation

This Form 4 reports routine insider transactions, including a small share acquisition and a significant option grant, both under a 10b5-1 plan. While the option grant aligns executive incentives with long-term shareholder value, the filing does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as it reflects no new fundamental catalysts from this specific filing.

Keywords

Scotts Miracle-Gro, SMG, Insider Trading, Form 4, Stock Options, Executive Compensation, Mark J. Scheiwer, 10b5-1 Plan, Common Shares